NGM Biopharmaceuticals Inc (NASDAQ:NGM)
| 12.35 BATS BZX Real-Time Price As of 2:05pm ET |  -0.02 / -0.16%Today’s Change | 10.49 Today|||52-Week Range 21.63 | -30.27% Year-to-Date |
Latest NGM News | Press Releases
No recent news for NGM Biopharmaceuticals Inc.
Today’s Trading
| Previous close | 12.37 |
| Today’s open | 12.07 |
| Day’s range | 11.88 - 12.44 |
| Volume | 21,459 |
| Average volume (3 months) | 466,600 |
| Market cap | $1.1B |
Data as of 2:05pm ET, 10/07/2022
Growth & Valuation
| Earnings growth (last year) | -4.30% |
| Earnings growth (this year) | -42.52% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -10.86% |
| P/E ratio | NM |
| Price/Sales | 17.53 |
| Price/Book | 3.04 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RGNXRegenxbio Inc | -0.28 | -1.21% |
| MRUSMerus NV | -0.40 | -1.91% |
| EBSEmergent BioSolution... | -1.11 | -5.37% |
| QUREUniqure NV | -0.53 | -2.63% |
Data as of 2:06pm ET, 10/07/2022
Financials
| Next reporting date | November 16, 2022 |
| EPS forecast (this quarter) | -$0.61 |
| Annual revenue (last year) | $77.9M |
| Annual profit (last year) | -$120.3M |
| Net profit margin | -154.51% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
